Positive family history as a risk factor of obliterative atherosclerosis

Cor Et Vasa
|January 1, 1978
PubMed

Insights

A positive family history of peripheral artery disease (PAD) accelerates its development, particularly when combined with other risk factors. However, family history alone or with obesity does not significantly impact PAD progression.

Area of Science:

  • Vascular Medicine
  • Genetics
  • Epidemiology

Background:

  • Peripheral artery disease (PAD) is a significant vascular condition.
  • Family history is a known risk factor for cardiovascular diseases.
  • The specific role of family history in PAD progression requires further elucidation.

Purpose of the Study:

  • To investigate the influence of family history on the development of peripheral artery disease.
  • To determine the significance of a positive family history in conjunction with other risk factors for PAD.

Main Methods:

  • Clinical, angiological, and biochemical examinations of patients with and without PAD.
  • Detailed family history recording, including myocardial infarction, cerebral accidents, hypertension, diabetes, and peripheral artery occlusive disease (PAOD) in relatives.
  • Statistical analysis of family history in combination with other risk factors.

Main Results:

  • A positive family history, defined by conditions like PAOD or early-onset cardiovascular events in relatives, is associated with accelerated PAD.
  • Family history plays a significant role only when combined with two or more additional risk factors, notably tobacco smoking.
  • Family history in combination with obesity did not show a significant impact on PAD.

Conclusions:

  • Positive family history is a contributing factor to PAD development and progression.
  • The interplay between genetic predisposition and lifestyle factors like smoking is crucial in PAD.
  • Obesity does not appear to modify the impact of family history on PAD.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...